Skip to main content

Table 1 The baseline characteristics of all participants

From: Increased risk of maternal and neonatal complications in hormone replacement therapy cycles in frozen embryo transfer

 

NC

N = 4727

HRT

N = 1642

OI

N = 517

p-value

Maternal age (year)

30.8 ± 4.0

30.5 ± 4.1

30.9 ± 4.1

0.109

BMI (kg/m2)

22.5 ± 3.2a,b

23.2 ± 3.4

22.8 ± 3.3

< 0.001*

Indications for IVF

 Tubal factor

2960 (62.6)

1025 (62.4)

325 (62.9)

0.981

 Male factor

1056 (22.3)

356 (21.7)

114 (22.1)

0.856

 Combined factors

566 (12.0)

201 (12.2)

60 (11.6)

0.919

 Others

145 (3.1)

60 (3.7)

18 (3.5)

0.486

Irregular menstruation, n (%)

267 (5.6)a,b

359 (21.9)

112 (21.7)

< 0.001*

Donor sperm using, n (%)

441 (9.3)

131 (8.0)

38 (7.4)

0.115

FET cycle number

1.2 ± 0.5a,b

1.3 ± 0.6c

1.6 ± 0.8

< 0.001*

No.of transferred embryos, n (%)

  = 1

4138 (87.5)

1455 (88.6)

453 (87.6)

0.516

  ≥ 2

589 (12.5)

187 (11.4)

64 (12.4)

0.516

Vanishing twin gestationd, n (%)

143 (3.0)

53 (3.2)

13 (2.5)

0.710

PFG (mmol/L)

5.2 ± 0.5b

5.2 ± 0.5c

5.3 ± 0.5

0.002*

Systolic pressure (mmHg)

119.5 ± 11.8a,b

120.8 ± 11.6

120.7 ± 11.9

< 0.001*

Diastolic pressure (mmHg)

71.7 ± 8.7

72.4 ± 8.6

73.3 ± 8.8

< 0.001*

Endometrial thickness (mm)

10.0 ± 1.6a,b

9.5 ± 1.5c

9.3 ± 1.7

< 0.001*

AFC

14.9 ± 5.9a

15.6 ± 6.6

15.3 ± 6.0

< 0.001*

Testosterone level (ng/dL)

24.4 ± 11.7a,b

26.0 ± 11.9

25.6 ± 12.5

< 0.001*

AMHe (ng/mL)

4.7 ± 3.7a

5.3 ± 3.6c

5.0 ± 3.5

< 0.001*

  1. NC natural cycle, HRT hormone replacement therapy, OI ovulation induction, BMI body mass index, FET frozen embryo transfer, PFG preconceptional fasting glucose, AFC Antral follicle count, AMH anti-müllerian hormone
  2. *There were significant differences among the three groups
  3. aThere were significant differences between NC and HRT group
  4. bThere were significant differences between NC and OI group
  5. cThere were significant differences between HRT and OI group
  6. d5 of the patients underwent selective reduction of triplet or quadruplet pregnancy. 7 of the patients were of triplet pregnancy yet lost two fetuses spontaneously during early pregnancy
  7. eThere were data missing in AMH, including 430 in NC group and 122 in HRT group and 39 in OI group